Elucidation of Proteasomal Non-catalytic Subunit PSMD2 as Potential Therapeutic Target and Its Co-upregulation with Proteasome Pathway Genes in Association with Various Clinicop athologic Features in Lung Adenocarcinomas.
Elucidation of Proteasomal Non-catalytic Subunit PSMD2 as Potential Therapeutic Target and Its Co-upregulation with Proteasome Pathway Genes in Association with Various Clinicop athologic Features in Lung Adenocarcinomas.
复制标题
阐明蛋白酶体非催化亚基 PSMD2 作为潜在治疗靶点及其与蛋白酶体途径基因的共同上调与肺腺癌各种临床病理特征的关系。
DOI：
--
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
et. al
中科院分区：
文献类型：
--
作者：
Matsuyama M.;et. al
